As your viral vector CDMO partner, we have the experience, expertise, and capabilities to guide your program from development, into clinical trials and through commercialization. Our Viral Vector Services (VVS) team has developed more than 60 different viral vectors and supported 10 manufacturing platforms to support brining therapies to market.
With over 60 products manufactured, we offer extensive experience transferring in, establishing, and optimizing viral vector processes. Development of cell culture processes to support:
Purification capabilities include:
Available services include:
We apply our deep process characterization experience and DoE methodology to define the CPPs and CQAs that enable robust processes, optimal yields, and effective control strategies.
Our approach and available services include:
Learn more about our end-to-end viral vector service capabilities.